EUVIMEDEUVIMED entdecken
Open Access

Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations

Kongyong Cui iD, Shaoyu Wu, Dong Yin, Weihua Song, Hongjian Wang, Chenggang Zhu, Lei Feng, Yuejin Yang, Rui Fu, Kefei Dou

Cardiology Journal · 2024

DOI: 10.5603/cj.93062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Journal, 2024. Verfasst von Kongyong Cui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sc…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Drug-Eluting Stents. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein(a) [Lp(a)] was positively associated with recurrent ischemic events in patients with acute coronary syndrome (ACS). This study was performed to investigate the effect of Lp(a) levels on outcomes of dual antiplatelet therapy (DAPT) > 1 year versus DAPT ≤ 1 year after percutaneous coronary intervention (PCI) in this population.

Methods

A total of 4,357 ACS patients who were event-free at 1 year after PCI were selected from the Fuwai PCI Registry, and patients were stratified into four groups according to DAPT duration (≤ 1 year vs. > 1 year) and Lp(a) levels (≤ 30 mg/dL vs. > 30 mg/dL). The primary endpoint was major adverse cardiovascular and cerebrovascular event (MACCE), defined as a composite of cardiac death, myocardial infarction or stroke.

Results

After 2.4-year follow-up, the incidence of MACCE (HRadjusted 0.284, 95% CI 0.115–0.700; HRIPTW 0.351, 95% CI 0.164–0.751) were significantly reduced in DAPT > 1 year group than that in DAPT ≤ 1 year group in individuals with elevated Lp(a) levels. However, in individuals with normal Lp(a) levels, no statistically difference was found between these two groups in terms of MACCE, although the risks of all-cause death and definite/probable stent thrombosis were lower in DAPT > 1 year group. Notably, the risk of clinically relevant bleeding did not statistically differ between these two groups in individuals with different Lp(a) levels.

Conclusions

This study firstly demonstrated that extended DAPT (> 1 year) was statistically associated with lower risk of ischemic events in ACS patients with elevated Lp(a) levels after PCI, whereas this association was not found in individuals with normal Lp(a) levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting StentsHumansPlatelet Aggregation InhibitorsLipoprotein(a)Drug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

acute coronary syndromedrug-eluting stentdual antiplatelet therapylipoprotein(a)percutaneous coronary interventionprognosis

Substanzen

Platelet Aggregation InhibitorsLipoprotein(a)

Autor:innen und Institutionen

  • Department of Cardiology, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Cardiovascular Disease, Beijing, China.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
  • Department of Cardiology, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. drdoukefei@12…
  • State Key Laboratory of Cardiovascular Disease, Beijing, China. drdoukefei@126.com.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, China. drdoukefei@126.com.

ORCID-Profile: Kongyong Cui

Zitieren

APA

Cui, K., Wu, S., Yin, D., Song, W., Wang, H., Zhu, C., Feng, L., Yang, Y., Fu, R., & Dou, K. (2024). Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations. Cardiology Journal. https://doi.org/10.5603/cj.93062

Vancouver

Cui K, Wu S, Yin D, Song W, Wang H, Zhu C, et al. Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations. Cardiology Journal. 2024. doi:10.5603/cj.93062

BibTeX
@article{Cui2024,
  author = {Cui, Kongyong and Wu, Shaoyu and Yin, Dong and Song, Weihua and Wang, Hongjian and Zhu, Chenggang and Feng, Lei and Yang, Yuejin and Fu, Rui and Dou, Kefei},
  title = {Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations},
  journal = {Cardiology Journal},
  year = {2024},
  doi = {10.5603/cj.93062}
}
Kostenlos starten →